ABVC BIOPHARMA INC's ticker is ABVC and the CUSIP is 00091F106.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $7,217 | +90112.5% | 13,879 | +4.7% | 0.00% | – |
| Q1 2023 | $8 | -11.1% | 13,254 | -7.0% | 0.00% | – |
| Q4 2022 | $9 | -99.9% | 14,248 | -5.6% | 0.00% | – |
| Q3 2022 | $13,000 | +116.7% | 15,098 | +151.8% | 0.00% | – |
| Q2 2022 | $6,000 | -25.0% | 5,997 | +71.7% | 0.00% | – |
| Q3 2021 | $8,000 | – | 3,492 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARMISTICE CAPITAL, LLC | 1,092,745 | $1,158,000 | 0.02% |
| VANGUARD GROUP INC | 375,142 | $398,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 49,915 | $52,000 | 0.00% |
| BlackRock Inc. | 39,042 | $41,000 | 0.00% |
| Tower Research Capital LLC (TRC) | 5,997 | $6,000 | 0.00% |